Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-25T08:20:56.269Z Has data issue: false hasContentIssue false
  • English
  • Français

Predisposing Factors and Antibiotic Use in Nosocomial Infections Caused by Xanthomonas maltophilia

Published online by Cambridge University Press:  21 June 2016

Darrell T. Hulisz  and
Thomas M. File
Darrell T. Hulisz*
Affiliation:
Ohio Northern University, Ada, Ohio
Thomas M. File
Affiliation:
Northeastern Ohio Universities Colleges of Medicine, Rootstown, Ohio
*
Pharmacotherapy Specialist, Akron General Medical Center, 400 Wabash Avenue, Akron, OH 44307
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 8 , August 1992 , pp. 489 - 490
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Marshall, WE Keating, MR, Anhalt, JR Steckelburg, JM. X maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc. 1989;64:1097–1104.CrossRefGoogle Scholar
2. Muder, RP, Yu, VL, Dummer, JS, Vinson, C, Lumish, RM. Infections caused by Pseudomonas maltophilia: expanding clinical spectrum. Arch Intern Med. 1987;147:1672–1674.CrossRefGoogle ScholarPubMed
3. Morrison, AJ, Hoffmann, KK, Wenzel, RP. Associated mortality and clinical characteristics of nosocomiai Pseudomonas maltophilia in a university hospital. J CLin Microbiol. 1986;24:52–55.CrossRefGoogle Scholar
4. Khardori, N, Elting, L, Wong, E, Schable, B, Bodey, GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis. 1990;12:997–1003.CrossRefGoogle Scholar
5. Eking, LS, Khadori, N, Bodey, GP, Fainstein, V. Nosocomial infection caused by X maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol. 1990;11:134–138.Google Scholar
6. Kerr, KG, Hawkey, PM, Child, JA, Norfolk, DR, Anderson, AW. Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem. Postgrad Med J. 1990;66:1090.CrossRefGoogle ScholarPubMed
7. Trumbore, D, Pontzer, R, Levison, ME, et al. Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections. Rev Infect Dis. 1985;7(suppl 3):S476–SS481.CrossRefGoogle ScholarPubMed
8. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC detinitions for nosocomiai infections, 1988. J Infect Control. 1988;16:128–140.CrossRefGoogle Scholar